These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27199372)

  • 1. DeepCAGE transcriptomics identify HOXD10 as a transcription factor regulating lymphatic endothelial responses to VEGF-C.
    Klein S; Dieterich LC; Mathelier A; Chong C; Sliwa-Primorac A; Hong YK; Shin JW; Lizio M; Itoh M; Kawaji H; Lassmann T; Daub CO; Arner E; ; Carninci P; Hayashizaki Y; Forrest AR; Wasserman WW; Detmar M
    J Cell Sci; 2016 Jul; 129(13):2573-85. PubMed ID: 27199372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-8: A potent promoter of human lymphatic endothelial cell growth in gastric cancer.
    Shi J; Li YJ; Yan B; Wei PK
    Oncol Rep; 2015 Jun; 33(6):2703-10. PubMed ID: 25891418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.
    Flister MJ; Wilber A; Hall KL; Iwata C; Miyazono K; Nisato RE; Pepper MS; Zawieja DC; Ran S
    Blood; 2010 Jan; 115(2):418-29. PubMed ID: 19901262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis.
    Shin JW; Huggenberger R; Detmar M
    Blood; 2008 Sep; 112(6):2318-26. PubMed ID: 18614759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
    Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z
    Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.
    Xiong Y; Liu Z; Zhao X; Ruan S; Zhang X; Wang S; Huang T
    Biomed Pharmacother; 2018 Oct; 106():1-7. PubMed ID: 29940537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress-dependent VEGF-C signaling.
    Geng X; Yanagida K; Akwii RG; Choi D; Chen L; Ho Y; Cha B; Mahamud MR; Berman de Ruiz K; Ichise H; Chen H; Wythe JD; Mikelis CM; Hla T; Srinivasan RS
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32544090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α.
    Min Y; Ghose S; Boelte K; Li J; Yang L; Lin PC
    Oncogene; 2011 Dec; 30(49):4901-9. PubMed ID: 21666710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway.
    Yu J; Zhang X; Kuzontkoski PM; Jiang S; Zhu W; Li DY; Groopman JE
    Cell Commun Signal; 2014 Apr; 12():25. PubMed ID: 24708522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HHEX is a transcriptional regulator of the VEGFC/FLT4/PROX1 signaling axis during vascular development.
    Gauvrit S; Villasenor A; Strilic B; Kitchen P; Collins MM; Marín-Juez R; Guenther S; Maischein HM; Fukuda N; Canham MA; Brickman JM; Bogue CW; Jayaraman PS; Stainier DYR
    Nat Commun; 2018 Jul; 9(1):2704. PubMed ID: 30006544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
    Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
    Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis.
    Durré T; Morfoisse F; Erpicum C; Ebroin M; Blacher S; García-Caballero M; Deroanne C; Louis T; Balsat C; Van de Velde M; Kaijalainen S; Kridelka F; Engelholm L; Struman I; Alitalo K; Behrendt N; Paupert J; Noel A
    Nat Commun; 2018 Dec; 9(1):5178. PubMed ID: 30518756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtron microRNA-1236 inhibits VEGFR-3 signaling during inflammatory lymphangiogenesis.
    Jones D; Li Y; He Y; Xu Z; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):633-42. PubMed ID: 22223733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIP1 mediates vascular endothelial cell growth factor receptor-3-dependent angiogenic and lymphangiogenic responses.
    Zhou HJ; Chen X; Huang Q; Liu R; Zhang H; Wang Y; Jin Y; Liang X; Lu L; Xu Z; Min W
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):603-15. PubMed ID: 24407031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis.
    Dieterich LC; Tacconi C; Menzi F; Proulx ST; Kapaklikaya K; Hamada M; Takahashi S; Detmar M
    Angiogenesis; 2020 Aug; 23(3):411-423. PubMed ID: 32307629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
    Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
    Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.